Want to see TSE:EBM full AI Analyst Report?
Eastwood Bio-Medical Canada (EBM) Financial Statements
Eastwood Bio-Medical Canada Financial Overview
Eastwood Bio-Medical Canada's market cap is currently $130.88M. The company's EPS TTM is $-0.00; its P/E ratio is -612.90; Eastwood Bio-Medical Canada is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Jan 26 | Jan 25 | Oct 23 | Oct 22 | Jan 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 782.08K | $ 702.08K | $ 867.94K | $ 1.30M | $ 981.05K |
| Gross Profit | $ 506.03K | $ 454.39K | $ 440.51K | $ 902.74K | $ 458.37K |
| Operating Income | $ -354.70K | $ -437.70K | $ -506.04K | $ -128.76K | $ -590.89K |
| EBITDA | $ -309.73K | $ -342.05K | $ -410.58K | $ -32.33K | $ -495.50K |
| Net Income | $ -332.77K | $ -455.87K | $ -546.60K | $ -160.58K | $ -611.34K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 17.70K | $ 0.00 | $ 18.45K | $ 39.84K | $ 20.87K |
| Total Assets | $ 218.77K | $ 274.29K | $ 489.14K | $ 584.53K | $ 691.12K |
| Total Debt | $ 78.01K | $ 79.61K | $ 23.08K | $ 62.25K | $ 31.35K |
| Net Debt | $ 60.30K | $ 79.61K | $ 4.63K | $ 22.41K | $ 10.48K |
| Total Liabilities | $ 1.85M | $ 1.57M | $ 1.33M | $ 878.73K | $ 835.44K |
| Stockholders' Equity | $ -1.63M | $ -1.30M | $ -840.80K | $ -294.20K | $ -144.32K |
| Cash Flow | |||||
| Free Cash Flow | $ 19.30K | $ -15.22K | $ -16.89K | $ -7.30K | $ -121.79K |
| Operating Cash Flow | $ 19.30K | $ -15.22K | $ -16.89K | $ -4.29K | $ -116.21K |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ -3.00K | $ -5.57K |
| Financing Cash Flow | $ -211.00 | $ -4.62K | $ -4.50K | $ 26.27K | $ 20.00K |
Currency in CAD